PSORCON Drug Patent Profile

✉ Email this page to a colleague

When do Psorcon patents expire, and when can generic versions of Psorcon launch?

Psorcon is a drug marketed by Taro Pharms North and Pfizer and is included in three NDAs.

The generic ingredient in PSORCON is diflorasone diacetate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Psorcon

A generic version of PSORCON was approved as diflorasone diacetate by AVONDALE PHARMS on April 27^th, 1999.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PSORCON?
What are the global sales for PSORCON?
What is Average Wholesale Price for PSORCON?

Summary for PSORCON

US Patents:	0
Applicants:	2
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	59
Patent Applications:	5,710
DailyMed Link:	PSORCON at DailyMed

Drug patent expirations by year for PSORCON

US Patents and Regulatory Information for PSORCON

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharms North	PSORCON	diflorasone diacetate	CREAM;TOPICAL	020205-001	Nov 20, 1992		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	PSORCON	diflorasone diacetate	OINTMENT;TOPICAL	019260-001	Aug 28, 1985		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	PSORCON E	diflorasone diacetate	OINTMENT;TOPICAL	017994-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PSORCON

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	PSORCON	diflorasone diacetate	OINTMENT;TOPICAL	019260-001	Aug 28, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PSORCON

See the table below for patents covering PSORCON around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	S5344465		⤷ Sign Up
Germany	2365992		⤷ Sign Up
Canada	995663	ANTI-INFLAMMATORY STEROID AND PROCESSES FOR ITS PREPARATION	⤷ Sign Up
South Africa	7301164		⤷ Sign Up
Japan	S5344464		⤷ Sign Up
Germany	2710880		⤷ Sign Up
Argentina	197216	PROCEDIMIENTO PARA PRODUCIR 17,21-DIACETATO DE 6ALPHA,9ALPHA-DIFLUORO-11BETA,17,21-TRIHIDROXI-16BETA-METIL-PREGNA-1,4-DIEN-3,20-DIONA	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for PSORCON

Make Better Decisions: Try a trial or see plans & pricing